Pain News and Research

Latest Pain News and Research

Potential new strategy for treating lupus

Immune cells that would normally die in healthy people accumulate in bodies of patients who have lupus and contribute to the disease, according to new Saint Louis University research published in the Feb. 15 issue of Immunity.

17 Feb 2008

New spine center at UT Southwestern

UT Southwestern Medical Center has launched a multidisciplinary Spine Center that features top physicians from diverse fields who work together to treat one of the most common problems plaguing our aging society: back pain.

14 Feb 2008

Giving birth to a boy can lead to higher levels of severe post-natal depression

Giving birth to a boy can lead to higher levels of severe post-natal depression (PND) and reduced quality of life than having a girl, according to research published in the February issue of Journal of Clinical Nursing.

14 Feb 2008

Throwing money at back pain treatments does not guarantee relief

A new study by researchers in the United States has revealed that despite the billions of dollars spent in recent years on treating back pain, many people gain little relief.

13 Feb 2008

Patients with large support network of family and friends fare better after an operation

A new study published in the February issue of the Journal of the American College of Surgeons shows that patients with a large support network of family and friends report feeling less pain and anxiety prior to having a surgical procedure, which can have a substantially positive impact on their postoperative recovery.

13 Feb 2008

Expenditures rising for back and neck problems, but health outcomes do not appear to be improving

Although expenses related to back and neck problems have increased substantially in the last decade, outcomes such as functional disability and work limitations do not appear to be improving, according to a study in the February 13 issue of JAMA.

13 Feb 2008

New non-invasive imaging method for diagnosing osteoarthritis

Researchers at New York University and Tel Aviv University have developed a non-invasive imaging method that can be used to diagnose and monitor a number of diseases, including osteoarthritis and inter-vertebral disc degeneration, in their early stages.

12 Feb 2008

Doctors uncertain about approaches to care for heart failure patients

Less than one fourth of physicians specializing in geriatrics, internal or family medicine or cardiology believe they can accurately predict the whether patients with heart failure are at risk of dying, new Saint Louis University research found.

12 Feb 2008

Researchers find new U.S. trend in antibiotic resistance

A research team from The University of Texas Health Science Center at San Antonio, examining bacterial isolates obtained in hospital and non-hospital clinical settings between 2000 and 2006, has identified drug-resistant strains of E. coli and Klebsiella bacteria in more than 50 blood, urine and respiratory samples.

11 Feb 2008

Team approach to treating depression cuts medical costs

A team approach to treating depression in older adults, already shown to improve health, can also cut total health-care costs, according to a new study led by the University of Washington.

8 Feb 2008

New cements for vertebral lesions

A number of researchers at the Department of Polymer Science and Technology at the Chemistry Faculty from San Sebastian at the University of the Basque Country, led by Ms Isabel Goni and Ms Marilo Gurrutxaga, are studying new formulae for acrylic copolymers and compounds in order to obtain efficacious, multiuse bone cements with reduced side effects.

8 Feb 2008

Merck to pay over $650 million for fraudulent price reporting and kickbacks claims

Merck & Company has agreed to pay more than $650 million to resolve allegations that the pharmaceutical manufacturer failed to pay proper rebates to Medicaid and other government health care programs and paid illegal remuneration to health care providers to induce them to prescribe the company's products, the Justice Department has announced.

8 Feb 2008

Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells

Researchers are identifying innovative therapeutics for sickle cell anemia that focus on specific factors in the disease's progression, such as the important role of hydration of the red blood cells.

7 Feb 2008

FDA to stop the marketing of unapproved injectable colchicine

The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.

7 Feb 2008

Brain disturbances in chronic pain

People with unrelenting pain don't only suffer from the non-stop sensation of throbbing pain.

7 Feb 2008

Taking more than one NSAID may lead to complications

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to treat arthritis, which affects one-third of all adults.

5 Feb 2008

Enbrel shown to significantly reduced levels of C-reactive protein

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.

5 Feb 2008

Participants recruited for VCU study on premenstrual dysphoric disorder

The Virginia Commonwealth University Mood Disorders Institute is recruiting participants for a national study of a new treatment method for premenstrual dysphoric disorder, a severe and debilitating form of premenstrual syndrome, or PMS.

4 Feb 2008

Reducing pain could lead to increased immunization rates

Studies have shown that some parents are reluctant to have their children immunized because they fear their children will experience significant pain during and after the injections.

4 Feb 2008

FDA approves only once-daily inhaled corticosteroid for children

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved ASMANEX TWISTHALER 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a preventive therapy in patients 4 to 11 years of age.

4 Feb 2008